表紙
市場調查報告書

葡萄糖胺的全球市場:2020年∼2024年

Glucosamine Market by Application and Geography - Forecast and Analysis 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 917417
出版日期 內容資訊 英文 145 Pages
訂單完成後即時交付
價格
Back to Top
葡萄糖胺的全球市場:2020年∼2024年 Glucosamine Market by Application and Geography - Forecast and Analysis 2020-2024
出版日期: 2019年11月08日內容資訊: 英文 145 Pages
簡介

全球葡萄糖胺市場上,聯合治療的使用增加,在醫療保健產業的電子商務日益流行,老年人口的增加等成為成長促進因素,在預測期間內預計將以6%以上的年複合成長率擴大。但,由於分子類型變化的限制,替代品的廣泛可得性,及嚴格法規,可能妨礙在預測期間內葡萄糖胺產業的成長。

本報告提供全球葡萄糖胺市場相關調查分析,市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2019年)
  • 市場規模及預測(2019年∼2024年)

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各應用領域

  • 市場區隔:各應用領域
  • 各應用領域比較:市場規模及預測(2019年∼2024年)
  • 關節炎
  • 其他
  • 市場機會:各應用領域

第7章 客戶形勢

第8章 各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2019年∼2024年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • 慢性疾病的治療中營養補充品的使用增加
  • 轉移到蔬菜來源的葡萄糖胺生產
  • 營養補充品領域的研究資金增加

第12章 業者情勢

  • 概要
  • 創造性破壞狀況
  • 競爭方案

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Blackmores Ltd.
  • Cargill Inc.
  • Ethical Naturals Inc.
  • GNC Holdings Inc.
  • Herbs Nutriproducts Pvt. Ltd.
  • Jyorana International Pvt. Ltd.
  • Natures Aid Ltd.
  • NOW Health Group Inc.
  • Pharma Nord Aps
  • WynnPharm Inc.

第14章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第15章 關於TECHNAVIO

目錄
Product Code: IRTNTR40086

About this market

Technavio's glucosamine market analysis considers sales from both arthritis and other applications. Our study also finds the sales of glucosamine in Asia, Europe, North America, and ROW. In 2018, the arthritis segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the rising transition to nutraceuticals and dietary supplements will play a significant role in the arthritis segment to maintain its market position. Also, our global glucosamine market report looks at factors such as increasing use of combination therapy, growing popularity of e-commerce in healthcare industry, and growing geriatric population. However, limitations on variation of molecule type, wide availability of substitutes, and stringent regulations may hamper the growth of the glucosamine industry over the forecast period.

Overview

Increasing the use of combination therapy

Although there are a substantial number of drugs available for the treatment of joint-related conditions, many researchers believe chronic conditions such as osteoarthritis do not respond to a monotherapy drug or a single treatment. Treatments of such conditions are most effective when given in combination. In combination therapy, nutraceutical supplements such as glucosamine are administered along with other drugs or dietary supplements such as chondroitin. Hence, the use of combination therapy will lead to the expansion of the global glucosamine market at a CAGR of over 6% during the forecast period.

Growing use of nutraceuticals in treating chronic diseases

Nutraceuticals such as glucosamine supplements are used to treat and manage various chronic diseases owing to their additional nutritional and therapeutic effects along with their health benefits and lesser side effects compared with drugs. A nutraceutical also offers physiological benefits such as protection against various chronic diseases and lifestyle disorders (obesity and cardiovascular diseases). Apart from effectively treating orthopedic conditions in combination therapy, glucosamine is also used to manage conditions such as interstitial cystitis, multiple sclerosis, and others. Vendors are also focusing on making non-animal-derived glucosamine to cater to individuals who are allergic to crustaceans and follow a kosher diet. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global glucosamine market during the forecast period 2020-2024, view our report.

Competitive Landscape

With the presence of several major players, the global glucosamine market is highly fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading glucosamine manufacturers, that include Blackmores Ltd., Cargill Inc., Ethical Naturals Inc., GNC Holdings Inc., Herbs Nutriproducts Pvt. Ltd., Jyorana International Pvt. Ltd., Natures Aid Ltd., NOW Health Group Inc., Pharma Nord Aps, and WynnPharm Inc.

Also, the glucosamine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY APPLICATION

  • Market segmentation by application
  • Comparison by application
  • Arthritis - Market size and forecast 2019-2024
  • Other applications - Market size and forecast 2019-2024
  • Market opportunity by application

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Growing use of nutraceuticals in treating chronic diseases
  • Shift toward production of glucosamine from vegetarian sources
  • Increasing research funding in the field of nutraceuticals

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Blackmores Ltd.
  • Cargill Inc.
  • Ethical Naturals Inc.
  • GNC Holdings Inc.
  • Herbs Nutriproducts Pvt. Ltd.
  • Jyorana International Pvt. Ltd.
  • Natures Aid Ltd.
  • NOW Health Group Inc.
  • Pharma Nord Aps
  • WynnPharm Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Key offerings
  • Exhibit 02: Global pharmaceuticals market
  • Exhibit 03: Segments of global pharmaceuticals market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Application - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by application
  • Exhibit 20: Arthritis - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: % Prevalence of arthritis by age in the US in 2013-15
  • Exhibit 22: Arthritis - Year-over-year growth 2020-2024 (%)
  • Exhibit 23: Other applications - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 24: Other applications - Year-over-year growth 2020-2024 (%)
  • Exhibit 25: Market opportunity by application
  • Exhibit 26: Customer landscape
  • Exhibit 27: Market share by geography 2019-2024 (%)
  • Exhibit 28: Geographic comparison
  • Exhibit 29: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 30: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 31: Top 3 countries in North America
  • Exhibit 32: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 33: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 34: Top 3 countries in Europe
  • Exhibit 35: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 36: Proportion of geriatric population in Asia 2009 and 2018 (% of the total population)
  • Exhibit 37: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 38: Top 3 countries in Asia
  • Exhibit 39: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 40: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 41: Top 3 countries in ROW
  • Exhibit 42: Key leading countries
  • Exhibit 43: Market opportunity
  • Exhibit 44: Growth of geriatric population 2009-2018 (%)
  • Exhibit 45: Alternative therapies for treating orthopedic conditions
  • Exhibit 46: Impact of drivers and challenges
  • Exhibit 47: Vendor landscape
  • Exhibit 48: Landscape disruption
  • Exhibit 49: Vendors covered
  • Exhibit 50: Vendor classification
  • Exhibit 51: Market positioning of vendors
  • Exhibit 52: Blackmores Ltd. - Vendor overview
  • Exhibit 53: Blackmores Ltd. - Business segments
  • Exhibit 54: Blackmores Ltd. - Organizational developments
  • Exhibit 55: Blackmores Ltd. - Segment focus
  • Exhibit 56: Blackmores Ltd. - Key offerings
  • Exhibit 57: Cargill Inc. - Vendor overview
  • Exhibit 58: Cargill Inc. - Business segments
  • Exhibit 59: Cargill Inc. - Organizational developments
  • Exhibit 60: Cargill Inc. - Geographic focus
  • Exhibit 61: Cargill Inc. - Key offerings
  • Exhibit 62: Ethical Naturals Inc. - Vendor overview
  • Exhibit 63: Ethical Naturals Inc. - Business segments
  • Exhibit 64: Ethical Naturals Inc. - Key offerings
  • Exhibit 65: GNC Holdings Inc. - Vendor overview
  • Exhibit 66: GNC Holdings Inc. - Business segments
  • Exhibit 67: GNC Holdings Inc. - Geographic focus
  • Exhibit 68: GNC Holdings Inc. - Segment focus
  • Exhibit 69: GNC Holdings Inc. - Key offerings
  • Exhibit 70: Herbs Nutriproducts Pvt. Ltd. - Vendor overview
  • Exhibit 71: Herbs Nutriproducts Pvt. Ltd. - Product segments
  • Exhibit 72: Herbs Nutriproducts Pvt. Ltd. - Key offerings
  • Exhibit 73: Jyorana International Pvt. Ltd. - Vendor overview
  • Exhibit 74: Jyorana International Pvt. Ltd. - Business segments
  • Exhibit 75: Jyorana International Pvt. Ltd. - Key offerings
  • Exhibit 76: Natures Aid Ltd. - Vendor overview
  • Exhibit 77: Natures Aid Ltd. - Product segments
  • Exhibit 78: Natures Aid Ltd. - Key offerings
  • Exhibit 79: NOW Health Group Inc. - Vendor overview
  • Exhibit 80: NOW Health Group Inc. - Product segments
  • Exhibit 81: NOW Health Group Inc. - Organizational developments
  • Exhibit 82: NOW Health Group Inc. - Key offerings
  • Exhibit 83: Pharma Nord Aps - Vendor overview
  • Exhibit 84: Pharma Nord Aps - Business segments
  • Exhibit 85: Pharma Nord Aps - Key offerings
  • Exhibit 86: WynnPharm Inc. - Vendor overview
  • Exhibit 87: WynnPharm Inc. - Product segments
  • Exhibit 88: WynnPharm Inc. - Key offerings
  • Exhibit 89: Validation techniques employed for market sizing
  • Exhibit 90: Definition of market positioning of vendors
Back to Top